Detection of Toxigenic Clostridium difficile: Comparison of the Cell Culture Neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile Assays
Authors:
Open Access
- 1 April 2012
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (4) , 1331-1335
Abstract
Clostridium difficile is the most important cause of nosocomial diarrhea. Several laboratory techniques are available to detect C. difficile toxins or the genes that encode them in fecal samples. We evaluated the Xpert C. difficile and Xpert C. difficile /Epi (Cepheid, CA) that detect the toxin B gene ( tcdB ) and tcdB , cdt , and a deletion in tcdC associated with the 027/NAP1/BI strain, respectively, by real-time PCR, and the Illumigene C. difficile (Meridian Bioscience, Inc.) that detects the toxin A gene ( tcdA ) by loop-mediated isothermal amplification in stool specimens. Toxigenic culture was used as the reference method for discrepant stool specimens. Two hundred prospective and fifty retrospective diarrheal stool specimens were tested simultaneously by the cell cytotoxin neutralization assay (CCNA) and the Xpert C. difficile , Xpert C. difficile /Epi, and Illumigene C. difficile assays. Of the 200 prospective stools tested, 10.5% ( n = 23) were determined to be positive by CCNA, 17.5% ( n = 35) were determined to be positive by Illumigene C. difficile , and 21.5% ( n = 43) were determined to be positive by Xpert C. difficile and Xpert C. difficile /Epi. Of the 50 retrospective stools, previously determined to be positive by CCNA, 94% ( n = 47) were determined to be positive by Illumigene C. difficile and 100% ( n = 50) were determined to be positive by Xpert C. difficile and Xpert C. difficile /Epi. Of the 11 discrepant results (i.e., negative by Illumigene C. difficile but positive by Xpert C. difficile and Xpert C. difficile /Epi), all were determined to be positive by the toxigenic culture. A total of 21% of the isolates were presumptively identified by the Xpert C. difficile /Epi as the 027/NAP1/BI strain. The Xpert C. difficile and Xpert C. difficile /Epi assays were the most sensitive, rapid, and easy-to use assays for the detection of toxigenic C. difficile in stool specimens.Keywords
This publication has 28 references indexed in Scilit:
- Laboratory Diagnosis of Clostridium difficile InfectionThe Journal of Molecular Diagnostics, 2011
- Molecular Methods and Platforms for Infectious Diseases TestingThe Journal of Molecular Diagnostics, 2011
- Impact of Clinical Symptoms on Interpretation of Diagnostic Assays for Clostridium difficile InfectionsJournal of Clinical Microbiology, 2011
- Evaluation of a Loop-Mediated Isothermal Amplification Assay for Diagnosis of Clostridium difficile InfectionsJournal of Clinical Microbiology, 2011
- Targeting the tcdA Gene: Is This Appropriate for Detection of A and/or B Clostridium difficile Toxin-Producing Strains?Journal of Clinical Microbiology, 2011
- Comparison of Strain Typing Results for Clostridium difficile Isolates from North AmericaJournal of Clinical Microbiology, 2011
- Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for Clostridium difficile Detection Challenges Cytotoxin B Cell Test and Culture as Gold StandardJournal of Clinical Microbiology, 2011
- Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer HospitalJournal of Clinical Microbiology, 2010
- Clostridium difficile Testing in the Clinical Laboratory by Use of Multiple Testing AlgorithmsJournal of Clinical Microbiology, 2010
- Comparative Phylogenomics of Clostridium difficile Reveals Clade Specificity and Microevolution of Hypervirulent StrainsJournal of Bacteriology, 2006